Feature story
E-cigarette company Juul boosts lobbying spending by 167 percent amid FDA scrutiny
WEDNESDAY, October 24, 2018 (USA Today)—Juul Labs has increased its spending on lobbying efforts by 167 percent in the third quarter from the previous quarter as the Food and Drug Administration and Congress continue to scrutinize the leading e-cigarette manufacturer over the popularity of its product with teenagers.
You might have also missed…
Immunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds
Oct. 22, CNN
Tobacco giant Philip Morris launches anti-smoking campaign
Oct. 22, CNBC
Can Eating Organic Food Lower Your Cancer Risk?
Oct. 23, The New York Times
Tall people at greater risk of cancer, study says
Oct. 24, CNN
